I never said the conference wasn't worthwhile - just that 1AD shouldn't be attending. It is a pointless exercise for them to continually pedal the same pre-clinical story until they have some hard data. The story is 'known' - it just isn't being 'bought' atm. And it annoys we that they are doing so so soon after a somewhat botched capital raising.
On reflection I'll stick with naive indignation.
- Forums
- ASX - By Stock
- Ann: AdAlta to present at 2019 Bioshares Biotech Summit
I never said the conference wasn't worthwhile - just that 1AD...
Featured News
Add 1AD (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.10M |
Open | High | Low | Value | Volume |
2.2¢ | 2.4¢ | 2.2¢ | $3.491K | 149.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1343533 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 6250 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1343533 | 0.022 |
1 | 4470 | 0.021 |
4 | 376841 | 0.020 |
2 | 81131 | 0.019 |
2 | 305553 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 6250 | 1 |
0.025 | 40056 | 2 |
0.026 | 100000 | 1 |
0.027 | 117643 | 2 |
0.028 | 125208 | 3 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
1AD (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online